ALTERATIONS IN THE LEVELS OF IRON, FERRITIN AND OTHER TRACE METALS IN PARKINSON'S DISEASE AND OTHER NEURODEGENERATIVE DISEASES AFFECTING THE BASAL GANGLIA

Cyclooxygenase-2 Directs Microglial Activation-Mediated Inflammation and Oxidative Stress Leading to Intrinsic Apoptosis in Zn-Induced Parkinsonism

Chauhan, A. K., Mittra, N., Patel, D. K., & Singh, C. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0455-0 · Cited by 23

Quantifying iron deposition in the cerebellar subtype of multiple system atrophy and spinocerebellar ataxia type 6 by quantitative susceptibility mapping

Sugiyama, A., Sato, N., Kimura, Y., et al. (2019) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2019.116525 · Cited by 23

Antioxidant Effects of SelegilIne in Oxidative Stress Induced by Iron Neonatal Treatment in Rats

Budni, P., de Lima, M. N. M., Polydoro, M., Moreira, J. C. F., Schröder, N., & Dal‐Pizzol, F. (2007) · Neurochemical Research · doi:10.1007/s11064-006-9249-x · Cited by 23

Serum and urinary manganese levels in patients with Parkinson's disease

Jiménez-Jiménez, F. J., Molina, J. A., Aguilar, M. V., Arrieta, F., Jorge‐Santamaría, A., Cabrera‐Valdivia, F., Ayuso‐Peralta, L., Rabasa, M., Vázquez, A., García-Albea, E., et al. (1995) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1995.tb07014.x · Cited by 23

The Role of Oxidative Stress in Signal Transduction Changes and Cell Loss in Senescence

Joseph, J. A., & Cutler, R. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb21787.x · Cited by 23

Inter-Organelle Crosstalk in Oxidative Distress: A Unified TRPM2-NOX2 Mediated Vicious Cycle Involving Ca2+, Zn2+, and ROS Amplification

Shitaw, E. E., AlAhmad, M., & Sivaprasadarao, A. (2025) · Antioxidants · doi:10.3390/antiox14070776 · Cited by 26

Iron deposition in Parkinsonisms: A Quantitative Susceptibility Mapping study in the deep grey matter

Fedeli, M. P., Contarino, V. E., Siggillino, S., Samoylova, N., Calloni, S. F., Melazzini, L., Conte, G., Sacilotto, G., Pezzoli, G., Triulzi, F. M., et al. (2020) · European Journal of Radiology · doi:10.1016/j.ejrad.2020.109394 · Cited by 21

Brain iron enrichment attenuates α‐synuclein spreading after injection of preformed fibrils

Joppe, K., Tatenhorst, L., Gomes, L. C., Zhang, S., Parvaz, M., Carboni, E., Roser, A., Eldebakey, H., Bähr, M., Vogel‐Mikuš, K., et al. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15461 · Cited by 23

Automatic detection of neuromelanin and iron in the midbrain nuclei using a magnetic resonance imaging ‐based brain template

Jin, Z., Wang, Y., Jokar, M., Li, Y., Cheng, Z., Liu, Y., Tang, R., Shi, X., Zhang, Y., Min, J., et al. (2022) · Human Brain Mapping · doi:10.1002/hbm.25770 · Cited by 22

Brainstem neuromelanin and iron MRI reveals a precise signature for idiopathic and LRRK2 Parkinson’s disease

Martı́nez, M., Ariz, M., Álvarez, I., et al. (2023) · npj Parkinson s Disease · doi:10.1038/s41531-023-00503-2 · Cited by 22

Iron is a specific cofactor for distinct oxidation- and aggregation-dependent Aβ toxicity mechanisms

Ott, S., Dziadulewicz, N., & Crowther, D. C. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.019042 · Cited by 23

Meta-analysis of the association between serum iron levels and Parkinson's disease: Evidence from 11 publications

Jiao, J., Guo, H., He, Y., Wang, J., Yuan, J., & Hu, W. (2016) · Brain Research · doi:10.1016/j.brainres.2016.06.044 · Cited by 22

Oxidative stress detection: what for? Part I.

Palmieri, B., & Sblendorio (2006) · PubMed · Cited by 21

Aging and Oxidative Stress Response in the CNS

Calabrese, V., Butterfield, D. A., & Stella, A. M. G. (2008) · Springer eBooks · doi:10.1007/978-0-387-32671-9_6 · Cited by 23

Nigrostriatal iron accumulation in the progression of Parkinson’s disease

López‐Aguirre, M., Balzano, T., Monje, M. H. G., Esteban-García, N., Martínez‐Fernández, R., del Rey, N. L., Ciorraga, M., Sánchez‐Ferro, Á., Trigo‐Damas, I., Blesa, J., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-00911-6 · Cited by 22

The interaction between metals and catecholamines: oxidative stress, DNA damage, and implications for human health

Cassera, E., Ferrari, E., Vignati, D. A. L., & Capucciati, A. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111366 · Cited by 24

Antagonistic pleiotropic effects of nitric oxide in the pathophysiology of Parkinson's disease

Tripathy, D., Chakraborty, J., & Mohanakumar, K. P. (2015) · Free Radical Research · doi:10.3109/10715762.2015.1045505 · Cited by 21

The Role of Xenobiotics and Trace Metals in Parkinson’s Disease

Bjørklund, G., Dadar, M., Chirumbolo, S., & Aaseth, J. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01832-1 · Cited by 20

Elemental quantification and analysis of structural abnormalities in neurons from Parkinson’s-diseased brains by X-ray fluorescence microscopy and diffraction

Joppe, K., Nicolas, J., Grünewald, T. A., Eckermann, M., Salditt, T., & Lingor, P. (2020) · Biomedical Optics Express · doi:10.1364/boe.389408 · Cited by 21

The Association between Serum Oxidative Stress Indexes and Pathogenesis of Parkinson's Disease in the Northwest of Iran

Barmaki, H., Morovati, A., Eydivandi, Z., Naleshkenani, F. J., Saedi, S., Musavi, H., Abbasi, M., & Hemmati-Dinarvand, M. (2021) · Iranian Journal of Public Health · doi:10.18502/ijph.v50i3.5621 · Cited by 19

Combined Application of Quantitative Susceptibility Mapping and Diffusion Kurtosis Imaging Techniques to Investigate the Effect of Iron Deposition on Microstructural Changes in the Brain in Parkinson’s Disease

Yang, L., Cheng, Y. Z., Sun, Y., Xuan, Y., Niu, J., Guan, J., Rong, Y., Jia, Y., Zhuang, Z., Yan, G., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.792778 · Cited by 24

Diagnostic accuracy of quantitative susceptibility mapping in multiple system atrophy: The impact of echo time and the potential of histogram analysis

Lancione, M., Cencini, M., Costagli, M., et al. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2022.102989 · Cited by 22

Defective Mitochondrial Dynamics and Protein Degradation Pathways Underlie Cadmium-Induced Neurotoxicity and Cell Death in Huntington’s Disease Striatal Cells

Kamitsuka, P. J., Ghanem, M. M., Ziar, R., McDonald, S. E., Thomas, M. G., & Kwakye, G. F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087178 · Cited by 20

Inflammation in Metal-Induced Neurological Disorders and Neurodegenerative Diseases

Wei, R., Wei, P., Yuan, H., Yi, X., Aschner, M., Jiang, Y., & Li, S. (2024) · Biological Trace Element Research · doi:10.1007/s12011-023-04041-z · Cited by 24

Dynamic modeling of α-synuclein aggregation in dopaminergic neuronal system indicates points of neuroprotective intervention: experimental validation with implications for Parkinson's therapy

Sultana, Z., Paleologou, K. E., Al-Mansoori, K. M., Ardah, M. T., Singh, N., Usmani, S., Jiao, H., Martin, F. L., Bharath, M. M. S., Vali, S., et al. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.10.018 · Cited by 21

Redox Sensitivity of Tyrosine Hydroxylase Activity and Expression in Dopaminergic Dysfunction

Giovanni, G. D., Pessia, M., & Maio, R. D. (2012) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152712800792938 · Cited by 21

T1ρ imaging in premanifest Huntington disease reveals changes associated with disease progression

Wassef, S. N., Wemmie, J. A., Johnson, C. P., Johnson, H. J., Paulsen, J. S., Long, J. D., & Magnotta, V. A. (2015) · Movement Disorders · doi:10.1002/mds.26203 · Cited by 21

Iron, Aging, and Neurodegeneration

Angelova, D. M., & Brown, D. R. (2015) · Metals · doi:10.3390/met5042070 · Cited by 23

Quantification of iron in the non-human primate brain with diffusion-weighted magnetic resonance imaging

Fujiwara, S., Uhrig, L., Amadon, A., Jarraya, B., & Bihan, D. L. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2014.08.049 · Cited by 21

Loss of ATP13A2 impairs glycolytic function in Kufor-Rakeb syndrome patient-derived cell models

Park, J., Koentjoro, B., Davis, R. L., & Sue, C. M. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.03.018 · Cited by 22

α-Synuclein Enhances Cadmium Uptake and Neurotoxicity via Oxidative Stress and Caspase Activated Cell Death Mechanisms in a Dopaminergic Cell Model of Parkinson’s Disease

Chong, W., Jiménez, J. A., McIIvin, M., Saito, M. A., & Kwakye, G. F. (2017) · Neurotoxicity Research · doi:10.1007/s12640-017-9725-x · Cited by 23

Imaging Parkinsonian Pathology in Substantia Nigra with MRI

Huddleston, D. E., Langley, J. A., Dušek, P., He, N., Faraco, C. C., Crosson, B., Factor, S. A., & Hu, X. P. (2018) · Current Radiology Reports · doi:10.1007/s40134-018-0272-x · Cited by 21

Iron-mediated interaction of alpha synuclein with lipid raft model membranes

Perissinotto, F., Stani, C., Cecco, E. D., Vaccari, L., Rondelli, V., Posocco, P., Parisse, P., Scaini, D., Legname, G., & Casalis, L. (2020) · Nanoscale · doi:10.1039/d0nr00287a · Cited by 21

What is it? case 1, 1996: Rapidly progressive parkinsonism, incontinence, impotency, and levodopa‐induced moaning in a patient with multiple myeloma

Fahn, S., Brin, M. F., Dwork, A. J., et al. (1996) · Movement Disorders · doi:10.1002/mds.870110314 · Cited by 21

Tyrosine hydroxylase: mechanisms of oxygen radical formation

Adams, J. D., Jr., Klaidman, L. K., & Ribeiro, P. (1997) · Redox Report · doi:10.1080/13510002.1997.11747123 · Cited by 21

Nigral ATP13A2 depletion induces Parkinson’s disease-related neurodegeneration in a pilot study in non-human primates

Sikora, J., Doveró, S., Kinet, R., Arotçarena, M.-L., Bohic, S., Bézard, E., Fernagut, P., & Dehay, B. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-024-00757-4 · Cited by 22

Pretreatment with Human Lactoferrin Had a Positive Effect on the Dynamics of Mouse Nigrostriatal System Recovery after Acute MPTP Exposure

Kopaeva, M. Y., Cherepov, A. B., Nesterenko, M. V., & Zarayskaya, I. Y. (2021) · Biology · doi:10.3390/biology10010024 · Cited by 20

Therapeutic potential of iron modulating drugs in a mouse model of multiple system atrophy

Shukla, J. J., Stefanova, N., Bush, A. I., McColl, G., Finkelstein, D. I., & McAllum, E. J. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105509 · Cited by 19

Potential prevention and treatment of neurodegenerative disorders by olive polyphenols and hidrox

Ontario, M. L., Siracusa, R., Modafferi, S., Scuto, M. C., Sciuto, S., Greco, V., Bertuccio, M. P., Salinaro, A. T., Crea, R., Calabrese, E. J., et al. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111637 · Cited by 20

Intranasal Rotenone Induces Alpha-Synuclein Accumulation, Neuroinflammation and Dopaminergic Neurodegeneration in Middle-Aged Mice

Sharma, M., Sharma, N., & Khairnar, A. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03847-y · Cited by 20

Dl-3-n-butylphthalide activates Nrf2, inhibits ferritinophagy, and protects MES23.5 dopaminergic neurons from ferroptosis

Ye, Z., Li, C., Liu, S., Liang, H., Feng, J., Lin, D., Chen, Y., Peng, S., Bu, L., Tao, E., et al. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110604 · Cited by 20

Is Brain Copper Deficiency in Alzheimer's, Lewy Body, and Creutzfeldt Jakob Diseases the Common Key for a Free Radical Mechanism and Oxidative Stress-Induced Damage?

Deloncle, R., & Guillard, O. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140765 · Cited by 20

Evaluation of tetrathiomolybdate in the R6/2 model of Huntington disease

Tallaksen‐Greene, S. J., Janiszewska, A., Benton, K., Hou, G., Dick, R., Brewer, G. J., & Albin, R. L. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.01.040 · Cited by 20

Impaired antioxidant status and reduced energy metabolism in autistic children

Essa, M. M., Braidy, N., Waly, M. I., Al-Farsi, Y. M., Al‐Sharbati, M. M., Subash, S., Amanat, A., Al-Shaffaee, M. A., & Guillemin, G. J. (2013) · Research in Autism · doi:10.1016/j.rasd.2012.12.006 · Cited by 20

Iron quantification in Parkinson's disease using an age-based threshold on susceptibility maps: The advantage of local versus entire structure iron content measurements

Sethi, S. K., Kisch, S. J., Ghassaban, K., et al. (2018) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2018.10.001 · Cited by 20

Repin-Induced Neurotoxicity in Rodents

Robles, M., Choi, B. H., Han, B., Cruz, K. S., & Kim, R. C. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6826 · Cited by 20

Ellagic Acid Modulates Uninduced as well as Mutation and Metal-Induced Aggregation of α-Synuclein: Implications for Parkinson’s Disease

Meena, V. K., Kumar, V., Karalia, S., Garima, & Sundd, M. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00317 · Cited by 20

The Compound ATH434 Prevents Alpha-Synuclein Toxicity in a Murine Model of Multiple System Atrophy

Finkelstein, D. I., Shukla, J. J., Cherny, R. A., Billings, J. L., Saleh, E., Stefanova, N., Barnham, K. J., & Adlard, P. A. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-212877 · Cited by 20

The Relationships Among Metal Homeostasis, Mitochondria, and Locus Coeruleus in Psychiatric and Neurodegenerative Disorders: Potential Pathogenetic Mechanism and Therapeutic Implications

Nakagawa, Y., & Yamada, S. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-022-01234-3 · Cited by 20

Zinc in Regulating Protein Kinases and Phosphatases in Neurodegenerative Diseases

Zhang, H.-L., Wang, X., & Liu, R. (2022) · Biomolecules · doi:10.3390/biom12060785 · Cited by 20

Disease-Toxicant Interactions in Parkinson’s Disease Neuropathology

Kwakye, G. F., McMinimy, R. A., & Aschner, M. (2016) · Neurochemical Research · doi:10.1007/s11064-016-2052-4 · Cited by 21

Synchrotron XRF imaging of Alzheimer’s disease basal ganglia reveals linear dependence of high-field magnetic resonance microscopy on tissue iron concentration

Finnegan, M. E., Visanji, N. P., Romero‐Canelón, I., House, E. R., Rajan, S., Mosselmans, J. F. W., Hazrati, L., Dobson, J., & Collingwood, J. F. (2019) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2019.03.002 · Cited by 19

Zn homeostasis in genetic models of Parkinson’s disease in Caenorhabditis elegans

Baesler, J., Kopp, J. F., Pohl, G., Aschner, M., Haase, H., Schwerdtle, T., & Bornhorst, J. (2019) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2019.05.005 · Cited by 18

Pathological characterization of T2*-weighted MRI contrast in the striatum of Huntington’s disease patients

Bulk, M., Hegeman-Kleinn, I. M., Kenkhuis, B., Suidgeest, E., van Roon‐Mom, W., Lewerenz, J., van Duinen, S. G., Ronen, I., & van der Weerd, L. (2020) · NeuroImage Clinical · doi:10.1016/j.nicl.2020.102498 · Cited by 19

Quantitative susceptibility mapping and blood neurofilament light chain differentiate between parkinsonian disorders

Zhang, P., Chen, J., Cai, T., He, C., Li, Y., Li, X., Chen, Z., Wang, L., & Zhang, Y. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.909552 · Cited by 19

Serum Cholesterol and Nigrostriatal R2* Values in Parkinson's Disease

Du, G., Lewis, M. M., Shaffer, M. L., Chen, H., Yang, Q. X., Mailman, R. B., & Huang, X. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035397 · Cited by 19

Role of N-terminal methionine residues in the redox activity of copper bound to alpha-synuclein

Rodríguez, E. E., Arcos‐López, T., Trujano-Ortiz, L. G., Fernández, C. O., González, F. J., Vela, A., & Quintanar, L. (2016) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-016-1376-5 · Cited by 19

Short-term manganese pretreatment partially protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity

Rojas, P., & R�os, C. (1995) · Neurochemical Research · doi:10.1007/bf00995386 · Cited by 19

On the Chemical and Biological Characteristics of Multifunctional Compounds for the Treatment of Parkinson’s Disease

García‐Beltrán, O., Urrutia, P. J., & Núñez, M. T. (2023) · Antioxidants · doi:10.3390/antiox12020214 · Cited by 19

Bioinorganic Chemistry of Micronutrients Related to Alzheimer’s and Parkinson’s Diseases

Kola, A., Nencioni, F., & Valensin, D. (2023) · Molecules · doi:10.3390/molecules28145467 · Cited by 18

Iron deposition in subcortical nuclei of Parkinson’s disease: A meta-analysis of quantitative iron-sensitive magnetic resonance imaging studies

Jin, J., Su, D., Zhang, J., Lam, J. S. T., Zhou, J., & Feng, T. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003167 · Cited by 18

Sonographic Alteration of Lenticular Nucleus in Focal Task-Specific Dystonia of Musicians

Walter, U., Buttkus, F., Benecke, R. M., et al. (2011) · Neurodegenerative Diseases · doi:10.1159/000330712 · Cited by 18

Susceptibility-weighted MRI of extrapyramidal brain structures in Parkinsonian disorders

Schneider, E., Ng, K.-M., Yeoh, C.-S., et al. (2016) · Medicine · doi:10.1097/md.0000000000003730 · Cited by 18

Regulation of quinolinic acid neosynthesis in mouse, rat and human brain by iron and iron chelators in vitro

Stachowski, E. K., & Schwarcz, R. M. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0694-6 · Cited by 18

The Role of Iron Imaging in Huntington’s Disease

van den Bogaard, S. J. A., Dumas, E. M., & Roos, R. A. C. (2013) · International review of neurobiology · doi:10.1016/b978-0-12-410502-7.00011-9 · Cited by 18

Neuroleptic induced parkinsonism: MRI findings in relation to clinical course after withdrawal of neuroleptic drugs.

Bocola, V., Fabbrini, G., Sollecito, A., et al. (1996) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.60.2.213 · Cited by 18

Cloning of human 3-hydroxyanthranilic acid dioxygenase in Escherichia coli: characterisation of the purified enzyme and its in vitro inhibition by Zn2+

Calderone, V., Trabucco, M., Menin, V., et al. (2002) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(02)00216-9 · Cited by 18

Trehalose Inhibits A53T Mutant α-Synuclein Overexpression and Neurotoxicity in Transduced PC12 Cells

Zhao, J., Zhi, X., Pan, L., & Zhou, P. (2017) · Molecules · doi:10.3390/molecules22081293 · Cited by 19

Metal homeostasis disturbances in neurodegenerative disorders, with special emphasis on Creutzfeldt-Jakob disease – Potential pathogenetic mechanism and therapeutic implications

Nakagawa, Y., & Yamada, S. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107455 · Cited by 18

Association between gene expression and functional‐metabolic architecture in Parkinson's disease

Zang, Z., Zhang, X., Song, T., Li, J., Nie, B., Mei, S., Hu, Z., Zhang, Y., & Lu, J. (2023) · Human Brain Mapping · doi:10.1002/hbm.26443 · Cited by 17

Novel mutations in PANK2 and PLA2G6 genes in patients with neurodegenerative disorders: two case reports

Dastsooz, H., Nemati, H., Fard, M. A. F., Fardaei, M., & Faghihi, M. A. (2017) · BMC Medical Genetics · doi:10.1186/s12881-017-0439-y · Cited by 17

ATP13A2 Declines Zinc-Induced Accumulation of α-Synuclein in a Parkinson’s Disease Model

Gao, H., Sun, H., Yan, N., Zhao, P., Xu, H. J., Zheng, W., Zhang, X., Wang, T., Guo, C., & Zhong, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23148035 · Cited by 21

Neuronal Nitric Oxide Synthase Negatively Regulates Zinc-Induced Nigrostriatal Dopaminergic Neurodegeneration

Singh, B. K., Kumar, V., Chauhan, A. K. S., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9857-7 · Cited by 17

Neurodegeneration and Aging of the Central Nervous System

Blaylock, R. L. (1998) · Integrative medicine · doi:10.1016/s1096-2190(98)00032-8 · Cited by 17

Neurobehavioural deficits following postnatal iron overload: I spontaneous motor activity

Fredriksson, A., Schröder, N., & Archer, T. (2003) · Neurotoxicity Research · doi:10.1007/bf03033373 · Cited by 17

Quinolinic acid neurotoxicity: In vivo increased copper and manganese content in rat corpus striatum after quinolinate intrastriatal injection

Santamarı́a, A., Rı́os, C., Pérez, P. V., et al. (1996) · Toxicology Letters · doi:10.1016/0378-4274(96)03772-1 · Cited by 17

Monoamine and Iron-Related Toxicity

Velez‐Pardo, C., Jiménez-Del-Río, M., Ebinger, G., & Vauquelin, G. (1998) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(97)00440-0 · Cited by 17

Copper homeostasis and cuproptosis: implications for neurodegenerative diseases

Tao, F., Lin, M., Meng, X., Huang, L., Zhuo, B., Jiang, S., Deng, S., Meng, Z., & Shi, J. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1688554 · Cited by 26

Postnatal zinc or paraquat administration increases paraquat or zinc-induced loss of dopaminergic neurons: insight into augmented neurodegeneration

Mittra, N., Chauhan, A. K. S., Singh, G., et al. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03694-x · Cited by 16

Iron accumulation in the oculomotor nerve of the progressive supranuclear palsy brain

Lee, H., Lee, M. J., Kim, E., Huh, G. Y., Lee, J., & Cho, H. (2021) · Scientific Reports · doi:10.1038/s41598-021-82469-w · Cited by 16

Parkinson’s disease or multiple system atrophy: potential separation by quantitative susceptibility mapping

Marxreiter, F., Lambrecht, V., Mennecke, A., et al. (2023) · Therapeutic Advances in Neurological Disorders · doi:10.1177/17562864221143834 · Cited by 16

The Neural Palette of Heme: Altered Heme Homeostasis Underlies Defective Neurotransmission, Increased Oxidative Stress, and Disease Pathogenesis

Soladogun, A. S., & Li, Z. (2024) · Antioxidants · doi:10.3390/antiox13121441 · Cited by 18

Volume of Interest Analysis of Spatially Normalized PRESTO Imaging to Differentiate between Parkinson Disease and Atypical Parkinsonian Syndrome

Sakurai, K., Imabayashi, E., Tokumaru, A. M., et al. (2016) · Magnetic Resonance in Medical Sciences · doi:10.2463/mrms.mp.2015-0132 · Cited by 16

Association of neurobehavioral performance with R2* in the caudate nucleus of asymptomatic welders

Lee, E.-Y., Eslinger, P. J., Flynn, M. R., Wagner, D., Du, G., Lewis, M. M., Kong, L., Mailman, R. B., & Huang, X. (2016) · NeuroToxicology · doi:10.1016/j.neuro.2016.11.007 · Cited by 16

Copper(II) Binding Sites in N-Terminally Acetylated α-Synuclein: A Theoretical Rationalization

Ramis, R., Ortega‐Castro, J., Vilanova, B., Adrover, M., & Frau, J. (2017) · The Journal of Physical Chemistry A · doi:10.1021/acs.jpca.7b03165 · Cited by 16

Zinc Potentiates Lipopolysaccharide-induced Nitric Oxide Production in Cultured Primary Rat Astrocytes

Moriyama, M., Fujitsuka, S., Kawabe, K., Takano, K., & Nakamura, Y. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2431-5 · Cited by 16

Quantitative susceptibility mapping depicts severe myelin deficit and iron deposition in a transgenic model of multiple system atrophy

Lambrecht, V., Hanspach, J., Hoffmann, A., Seyler, L., Mennecke, A., Straub, S., Marxreiter, F., Bäuerle, T., Laun, F. B., & Winkler, J. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113314 · Cited by 19

Functional Consequences of Iron Overload in Catecholaminergic Interactions: the Youdim Factor

Archer, T., & Fredriksson, A. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9358-1 · Cited by 16

Rôles biologiques des éléments traces dans le cerveau – exemples du Zn et du Fe

Bohic, S., Ghersi‐Egea, J., Gibon, J., Paoletti, P., Arnaud, J., Hunot, S., Boom, A., & Bouron, A. (2010) · Revue Neurologique · doi:10.1016/j.neurol.2010.07.035 · Cited by 16

Local striatal infusion of MPP+ does not result in increased hydroxylation after systemic administration of 4-hydroxybenzoate

Ste‐Marie, L., Vachon, L., Bémeur, C., Lambert, J., & Montgomery, J. A. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00170-7 · Cited by 16

Quantitative 7T Phase Imaging in Premanifest Huntington Disease

Apple, A. C., Possin, K. L., Satris, G., Johnson, E. T., Lupo, J., Jakary, A., Wong, K., Kelley, D. A. C., Kang, G. A., Sha, S. J., et al. (2014) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3932 · Cited by 15

Lack of toxicity of human neuromelanin to rat brain dopaminergic neurons

Aimi, Y., & McGeer, P. L. (1996) · Parkinsonism & Related Disorders · doi:10.1016/1353-8020(96)00004-1 · Cited by 16

Zinc increases the excitability of dopaminergic neurons in rat substantia nigra

Chung, J.-M., Chang, S.-Y., Kim, Y. I., & Shin, H.-C. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01120-4 · Cited by 16

Synthesis, Characterization, and Structures of Mn(DMHP)3·12H2O and Mn(DMHP)2Cl·0.5H2O

Hsieh, W., & Liu, S. (2005) · Inorganic Chemistry · doi:10.1021/ic0490627 · Cited by 16

Iron on trial: recasting the role of iron in neurodegeneration

Ayton, S., Moreau, C., Devos, D., & Bush, A. I. (2025) · Brain · doi:10.1093/brain/awaf398 · Cited by 18

Cerebrospinal Fluid Iron‐Ferritin Ratio as a Potential Progression Marker for Parkinson's Disease

Maass, F., Michalke, B., Willkommen, D., Canaslan, S., Schmitz, M., Bähr, M., Zerr, I., & Lingor, P. (2021) · Movement Disorders · doi:10.1002/mds.28790 · Cited by 15

Quantitative imaging approaches to understanding biological processing of metal ions

Zee, D. Z., MacRenaris, K. W., & O’Halloran, T. V. (2022) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2022.102152 · Cited by 15

ATH434 Rescues Pre-motor Hyposmia in a Mouse Model of Parkinsonism

Beauchamp, L. C., Liu, X. M., Vella, L. J., Adlard, P. A., Bush, A. I., Finkelstein, D. I., & Barnham, K. J. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01300-0 · Cited by 15

ATP13A2 (PARK9) and basal ganglia function

Croucher, K. M., & Fleming, S. M. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2023.1252400 · Cited by 17

Single-cell transcriptomic and neuropathologic analysis reveals dysregulation of the integrated stress response in progressive supranuclear palsy

Whitney, K. R., Song, W., Sharma, A., Dangoor, D. K., Farrell, K. W., Krassner, M. M., Ressler, H. W., Christie, T. D., Kandoi, S., Walker, R. H., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02823-w · Cited by 23

Visceral responses induced on excitation of caudate nucleus, putamen and globus pallidus.

Ghosh, M., & Mg, G. (1976) · PubMed · Cited by 1

Susceptibility weighted imaging evaluation of brain iron content of gray nucleus in healthy people

Ni, M.-F. (2009) · Zhongguo yixue yingxiang jishu

MR measurement of the basal ganglia volume in the Tourette syndrome

Liao, K., Guiping, L., & Yang, B. (2014) · Zhonghua fangshexian yixue zazhi · doi:10.3760/cma.j.issn.1005-1201.2014.02.002 · Cited by 1

Normal Aging in the Basal Ganglia Evaluated by Eigenvalues of Diffusion Tensor Imaging

Wang, Q., Xu, X., & Zhang, M. (2009) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1862 · Cited by 49

Differential aging of the human striatum: a prospective MR imaging study.

Gunning‐Dixon, F. M., Head, D. M., McQuain, J., Acker, J. D., & Raz, N. (1998) · PubMed Central · Cited by 178